Skip to main content
SpringerLink
Log in

Diabetic Retinopathy

  • Chapter
  • First Online:
Anti-Angiogenic Therapy in Ophthalmology

Part of the book series: Essentials in Ophthalmology ((ESSENTIALS))

  • 1085 Accesses

Abstract

Diabetic retinopathy (DR) is still the leading cause of vision loss in the working-aged adults worldwide (Yau et al. 2012), thereby causing a significant impairment in utility and quality of life. Forty years ago, persons with diabetes were 25 times more likely to become blind than people without diabetes (Kahn and Hiller 1974). However, over the last decades, lower incidences of diabetic retinopathy (DR) and rates of progression to proliferative retinopathy (PRD) were seen than historically (Ding and Wong 2012). The risk of severe visual loss has slightly decreased in the Western countries, which may reflect better control of glucose, blood pressure, and serum lipids as well as earlier diagnosis (Kempen et al. 2004).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 49.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Abouammoh MA. Ranibizumab injection for diabetic macular edema: meta-analysis of systemic safety and systematic review. Can J Ophthalmol. 2013;48(4):317–23.

    Article  PubMed  Google Scholar 

  • Agardh E, Cavallin-Sjoberg U. Peripheral retinal evaluation comparing fundus photographs with fluorescein angiograms in patients with diabetes mellitus. Retina. 1998;18(5):420–3.

    Article  CAS  PubMed  Google Scholar 

  • Ahsan H. Diabetic retinopathy—biomolecules and multiple pathophysiology. Diabetes Metab Syndr. 2015;9(1):51–4.

    Article  PubMed  Google Scholar 

  • Aiello LP, Beck RW, Bressler NM, et al. Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema. Ophthalmology. 2011;118(12):e5–14.

    Article  PubMed  PubMed Central  Google Scholar 

  • Al Dhibi HA, Arevalo JF. Clinical trials on corticosteroids for diabetic macular edema. World J Diabetes. 2013;4(6):295–302.

    Article  PubMed  PubMed Central  Google Scholar 

  • Alcubierre N, Rubinat E, Traveset A, et al. A prospective cross-sectional study on quality of life and treatment satisfaction in type 2 diabetic patients with retinopathy without other major late diabetic complications. Health Qual Life Outcomes. 2014;12:131.

    Article  PubMed  PubMed Central  Google Scholar 

  • American Diabetes Association (ADA). Standards of medical care in diabetes—2013. Diabetes Care. 2013;36 Suppl 1:S11–66.

    Article  CAS  Google Scholar 

  • Andreoli CM, Miller JW. Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol. 2007;18(6):502–8.

    Article  PubMed  Google Scholar 

  • Antonetti DA, Barber AJ, Bronson SK, et al. Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes. 2006;55(9):2401–11.

    Article  CAS  PubMed  Google Scholar 

  • Arden GB, Sivaprasad S. Hypoxia and oxidative stress in the causation of diabetic retinopathy. Curr Diabetes Rev. 2011;7(5):291–304.

    Article  CAS  PubMed  Google Scholar 

  • Ashton N. Diabetic microangiopathy. Bibl Ophthalmol. 1958;12(52):1–84.

    CAS  PubMed  Google Scholar 

  • Ashton N. Vascular basement membrane changes in diabetic retinopathy. Montgomery lecture, 1973. Br J Ophthalmol. 1974;58(4):344–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Avery RL. Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment. Retina. 2006;26(3):352–4.

    Article  PubMed  Google Scholar 

  • Banerjee S, Ghosh US, Biswas G, et al. Comparative evaluation of ophthalmoscopy and angiography for the assessment of retinopathy in type 2 diabetes mellitus. J Indian Med Assoc. 2007;105(1):33–6.

    PubMed  Google Scholar 

  • Beagley J, Guariguata L, Weil C, et al. Global estimates of undiagnosed diabetes in adults. Diabetes Res Clin Pract. 2014;103(2):150–60.

    Article  PubMed  Google Scholar 

  • Benson WE, Brown GC, Tasman W. Diabetes and its ocular complications. Philadelphia: Saunders; 1988.

    Google Scholar 

  • Bloom PA, Tsai JC, Sharma K, et al. “Cyclodiode”. Trans-scleral diode laser cyclophotocoagulation in the treatment of advanced refractory glaucoma. Ophthalmology. 1997;104(9):1508–19.

    Article  CAS  PubMed  Google Scholar 

  • Bolz M, Ritter M, Schneider M, et al. A systematic correlation of angiography and high-resolution optical coherence tomography in diabetic macular edema. Ophthalmology. 2009a;116(1):66–72.

    Article  PubMed  Google Scholar 

  • Bolz M, Schmidt-Erfurth U, Deak G, et al. Optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema. Ophthalmology. 2009b;116(5):914–20.

    Article  PubMed  Google Scholar 

  • Boyer DS, Yoon YH, Belfort Jr R, et al. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology. 2014;121(10):1904–14.

    Article  PubMed  Google Scholar 

  • Boynton GE, Stem MS, Kwark L, et al. Multimodal characterization of proliferative diabetic retinopathy reveals alterations in outer retinal function and structure. Ophthalmology. 2015;122:957–67.

    Article  PubMed  PubMed Central  Google Scholar 

  • Braun CI, Benson WE, Remaley NA, et al. Accommodative amplitudes in the Early Treatment Diabetic Retinopathy Study. Retina. 1995;15(4):275–81.

    Article  CAS  PubMed  Google Scholar 

  • Brechner RJ, Cowie CC, Howie LJ, et al. Ophthalmic examination among adults with diagnosed diabetes mellitus. JAMA. 1993;270(14):1714–8.

    Article  CAS  PubMed  Google Scholar 

  • Bresnick GH. Diabetic maculopathy. A critical review highlighting diffuse macular edema. Ophthalmology. 1983;90(11):1301–17.

    Article  CAS  PubMed  Google Scholar 

  • Bresnick GH, Haight B, de VG. Retinal wrinkling and macular heterotopia in diabetic retinopathy. Arch Ophthalmol. 1979;97(10):1890–95.

    Article  CAS  PubMed  Google Scholar 

  • Bressler NM, Miller KM, Beck RW, et al. Observational study of subclinical diabetic macular edema. Eye (Lond). 2012;26(6):833–40.

    Article  CAS  Google Scholar 

  • Bressler NM, Varma R, Doan QV, et al. Underuse of the health care system by persons with diabetes mellitus and diabetic macular edema in the United States. JAMA Ophthalmol. 2014;132(2):168–73.

    Article  PubMed  PubMed Central  Google Scholar 

  • Brinkmann R, Huttmann G, Rogener J, et al. Origin of retinal pigment epithelium cell damage by pulsed laser irradiance in the nanosecond to microsecond time regimen. Lasers Surg Med. 2000;27(5):451–64.

    Article  CAS  PubMed  Google Scholar 

  • Browning DJ, Glassman AR, Aiello LP, et al. Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology. 2007;114(3):525–36.

    Article  PubMed  Google Scholar 

  • Browning DJ, Altaweel MM, Bressler NM, et al. Diabetic macular edema: what is focal and what is diffuse? Am J Ophthalmol. 2008;146(5):649–55.

    Article  PubMed  PubMed Central  Google Scholar 

  • Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414(6865):813–20.

    Article  CAS  PubMed  Google Scholar 

  • Brucker AJ, Qin H, Antoszyk AN, et al. Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings. Arch Ophthalmol. 2009;127(2):132–40.

    Article  PubMed  Google Scholar 

  • Buabbud JC, Al-latayfeh MM, Sun JK. Optical coherence tomography imaging for diabetic retinopathy and macular edema. Curr Diab Rep. 2010;10(4):264–9.

    Article  PubMed  Google Scholar 

  • Byeon SH, Chu YK, Lee H, et al. Foveal ganglion cell layer damage in ischemic diabetic maculopathy: correlation of optical coherence tomographic and anatomic changes. Ophthalmology. 2009;116(10):|1949–59.

    Article  PubMed  Google Scholar 

  • Byeon SH, Chu YK, Hong YT, et al. New insights into the pathoanatomy of diabetic macular edema: angiographic patterns and optical coherence tomography. Retina. 2012;32(6):1087–99.

    Article  PubMed  Google Scholar 

  • Callanan DG, Gupta S, Boyer DS, et al. Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema. Ophthalmology. 2013;120(9):1843–51.

    Article  PubMed  Google Scholar 

  • Campochiaro PA, Brown DM, Pearson A, et al. Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema. Ophthalmology. 2011;118(4):626–35.

    Article  PubMed  Google Scholar 

  • Campochiaro PA, Brown DM, Pearson A, et al. Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema. Ophthalmology. 2012;119(10):2125–32.

    Article  PubMed  Google Scholar 

  • Campos C. Chronic hyperglycemia and glucose toxicity: pathology and clinical sequelae. Postgrad Med. 2012;124(6):90–7.

    Article  PubMed  Google Scholar 

  • Cardillo PF, Zingirian M, Mosci C. Classification of proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 1987;225(4):245–50.

    Article  Google Scholar 

  • Chalam KV, Bressler SB, Edwards AR, et al. Retinal thickness in people with diabetes and minimal or no diabetic retinopathy: Heidelberg Spectralis optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53(13):8154–61.

    Article  PubMed  PubMed Central  Google Scholar 

  • Chang YC, Wu WC. Dyslipidemia and diabetic retinopathy. Rev Diabet Stud. 2013;10(2–3):121–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chang-Lin JE, Burke JA, Peng Q, et al. Pharmacokinetics of a sustained-release dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes. Invest Ophthalmol Vis Sci. 2011;52(7):4605–9.

    Article  CAS  PubMed  Google Scholar 

  • Chantelau E, Meyer-Schwickerath R. Reversion of ‘early worsening’ of diabetic retinopathy by deliberate restoration of poor metabolic control. Ophthalmologica. 2003;217(5):373–7.

    Article  CAS  PubMed  Google Scholar 

  • Chen YJ, Kuo HK, Huang HW. Retinal outcomes in proliferative diabetic retinopathy presenting during and after pregnancy. Chang Gung Med J. 2004;27(9):678–84.

    PubMed  Google Scholar 

  • Chen G, Li W, Tzekov R, et al. Ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema: a meta-analysis of randomized controlled trials. PLoS One. 2014;9(12):e115797.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Chew EY, Klein ML, Murphy RP, et al. Effects of aspirin on vitreous/preretinal hemorrhage in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report no. 20. Arch Ophthalmol. 1995a;113(1):52–5.

    Article  CAS  PubMed  Google Scholar 

  • Chew EY, Mills JL, Metzger BE, et al. Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy Study. National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study. Diabetes Care. 1995b;18(5):631–7.

    Article  CAS  PubMed  Google Scholar 

  • Chew EY, Ambrosius WT, Davis MD, et al. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med. 2010;363(3):233–44.

    Article  PubMed  CAS  Google Scholar 

  • Chew EY, Davis MD, Danis RP, et al. The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study. Ophthalmology. 2014;121(12):2443–51.

    Article  PubMed  PubMed Central  Google Scholar 

  • Cho YH, Craig ME, Donaghue KC. Puberty as an accelerator for diabetes complications. Pediatr Diabetes. 2014;15(1):18–26.

    Article  CAS  PubMed  Google Scholar 

  • Clermont AC, Bursell SE. Retinal blood flow in diabetes. Microcirculation. 2007;14(1):49–61.

    Article  CAS  PubMed  Google Scholar 

  • Comyn O, Sivaprasad S, Peto T, et al. A randomized trial to assess functional and structural effects of ranibizumab versus laser in diabetic macular edema (the LUCIDATE study). Am J Ophthalmol. 2014;157(5):960–70.

    Article  CAS  PubMed  Google Scholar 

  • Congdon N, O’Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122(4):477–85.

    Article  PubMed  Google Scholar 

  • Cunha-Vaz JG. The blood-retinal barriers system. Basic concepts and clinical evaluation. Exp Eye Res. 2004;78(3):715–21.

    Article  CAS  PubMed  Google Scholar 

  • Cunha-Vaz J, Ashton P, Iezzi R, et al. Sustained delivery fluocinolone acetonide vitreous implants: long-term benefit in patients with chronic diabetic macular edema. Ophthalmology. 2014a;121(10):1892–903.

    Article  PubMed  Google Scholar 

  • Cunha-Vaz J, Ribeiro L, Lobo C. Phenotypes and biomarkers of diabetic retinopathy. Prog Retin Eye Res. 2014b;41:90–111.

    Article  CAS  PubMed  Google Scholar 

  • Daien V, Kawasaki R, Villain M, et al. Retinal vascular caliber is associated with renal function in apparently healthy subjects. Acta Ophthalmol. 2013;91(4):e283–8.

    Article  PubMed  Google Scholar 

  • Daley ML, Watzke RC, Riddle MC. Early loss of blue-sensitive color vision in patients with type I diabetes. Diabetes Care. 1987;10(6):777–81.

    Article  CAS  PubMed  Google Scholar 

  • Danis R, Davis M. Proliferative diabetic retinopathy. In: Duh E, editor. Diabetic retinopathy. Totowa: Humana Press; 2008. p. 29–65.

    Chapter  Google Scholar 

  • Davis MD, Fisher MR, Gangnon RE, et al. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Invest Ophthalmol Vis Sci. 1998;39(2):233–52.

    CAS  PubMed  Google Scholar 

  • Diabetes Control and Complications Trial (DCCT) Research Group. Color photography vs fluorescein angiography in the detection of diabetic retinopathy in the diabetes control and complications trial. Arch Ophthalmol. 1987;105(10):1344–51.

    Article  Google Scholar 

  • DCCT Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes. 1995;44(8):968–83.

    Article  Google Scholar 

  • DCCT Research Group. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. Diabetes Care. 2000;23(8):1084–91.

    Article  Google Scholar 

  • de S, Castilla M. Ocriplasmin for diabetic retinopathy. Expert Opin Biol Ther. 2013;13(12):1741–47.

    Article  CAS  Google Scholar 

  • De BU, Sacconi R, Pierro L, et al. Optical coherence tomographic hyperreflective foci in early stages of diabetic retinopathy. Retina. 2015;35(3):449–53.

    Article  Google Scholar 

  • Deissler H, Deissler H, Lang GK, et al. TGFbeta induces transdifferentiation of iBREC to alpha SMA-expressing cells. Int J Mol Med. 2006;18(4):577–82.

    CAS  PubMed  Google Scholar 

  • Deissler HL, Deissler H, Lang GK, et al. VEGF but not PlGF disturbs the barrier of retinal endothelial cells. Exp Eye Res. 2013;115:162–71.

    Article  CAS  PubMed  Google Scholar 

  • Delgado MF, Dickens CJ, Iwach AG, et al. Long-term results of noncontact neodymium:yttrium-aluminum-garnet cyclophotocoagulation in neovascular glaucoma. Ophthalmology. 2003;110(5):895–9.

    Article  PubMed  Google Scholar 

  • Diabetes Prevention Program (DPP) Research Group. The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program. Diabet Med. 2007;24(2):137–44.

    Article  Google Scholar 

  • Diabetic Retinopathy Clinical Research Network (DRCR.net), A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology. 2008;115(9):1447–9.

    Article  PubMed Central  Google Scholar 

  • Diabetic Retinopathy Study (DRS) Group. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol. 1976;81(4):383–96.

    Article  Google Scholar 

  • DRS Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. Ophthalmology. 1981a;88(7):583–600.

    Article  Google Scholar 

  • DRS Group. Report Number 6. Design, methods, and baseline results. Report Number 7. A modification of the Airlie House classification of diabetic retinopathy. Prepared by the Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 1981b;21(1 Pt 2):1–226.

    Google Scholar 

  • Ding J, Wong TY. Current epidemiology of diabetic retinopathy and diabetic macular edema. Curr Diab Rep. 2012;12(4):346–54.

    Article  PubMed  Google Scholar 

  • Dmuchowska DA, Krasnicki P, Mariak Z. Can optical coherence tomography replace fluorescein angiography in detection of ischemic diabetic maculopathy? Graefes Arch Clin Exp Ophthalmol. 2014;252(5):731–8.

    Article  PubMed  PubMed Central  Google Scholar 

  • Do YK, Eggleston KN. Educational disparities in quality of diabetes care in a universal health insurance system: evidence from the 2005 Korea National Health and Nutrition Examination Survey. Int J Qual Health Care. 2011;23(4):397–404.

    Article  PubMed  Google Scholar 

  • Do DV, Wang X, Vedula SS, et al. Blood pressure control for diabetic retinopathy. Cochrane Database Syst Rev. 2015;1:CD006127.

    PubMed  PubMed Central  Google Scholar 

  • Doft BH, Blankenship G. Retinopathy risk factor regression after laser panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology. 1984;91(12):1453–7.

    Article  CAS  PubMed  Google Scholar 

  • Douvali M, Chatziralli IP, Theodossiadis PG, et al. Effect of macular ischemia on intravitreal ranibizumab treatment for diabetic macular edema. Ophthalmologica. 2014;232(3):136–43.

    Article  CAS  PubMed  Google Scholar 

  • Dubow M, Pinhas A, Shah N, et al. Classification of human retinal microaneurysms using adaptive optics scanning light ophthalmoscope fluorescein angiography. Invest Ophthalmol Vis Sci. 2014;55(3):1299–309.

    Article  PubMed  PubMed Central  Google Scholar 

  • Dziuba J, Alperin P, Racketa J, et al. Modeling effects of SGLT-2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes. Diabetes Obes Metab. 2014;16(7):628–35.

    Article  CAS  PubMed  Google Scholar 

  • Edwards MS, Wilson DB, Craven TE, et al. Associations between retinal microvascular abnormalities and declining renal function in the elderly population: the Cardiovascular Health Study. Am J Kidney Dis. 2005;46(2):214–24.

    Article  PubMed  Google Scholar 

  • Ejaz S, Chekarova I, Ejaz A, et al. Importance of pericytes and mechanisms of pericyte loss during diabetes retinopathy. Diabetes Obes Metab. 2008;10(1):53–63.

    CAS  PubMed  Google Scholar 

  • Elman MJ, Aiello LP, Beck RW, et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2010;117(6):1064–77.

    Article  PubMed  PubMed Central  Google Scholar 

  • Elman MJ, Bressler NM, Qin H, et al. Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2011;118(4):609–14.

    Article  PubMed  PubMed Central  Google Scholar 

  • Elman MJ, Ayala A, Bressler NM, et al. Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results. Ophthalmology. 2015;122(2):375–81.

    Article  PubMed  PubMed Central  Google Scholar 

  • Escobar-Barranco JJ, Pina-Marin B, Fernandez-Bonet M. Dexamethasone implants in patients with naive or refractory diffuse diabetic macular edema. Ophthalmologica. 2015;233:176–85.

    Article  CAS  PubMed  Google Scholar 

  • Early Treatment Diabetic Retinopathy Study (ETDRS) Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol. 1985;103(12):1796–806.

    Article  Google Scholar 

  • ETDRS Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification ETDRS report number 10. Ophthalmology. 1991a;98(5 Suppl):786–806.

    Google Scholar 

  • ETDRS Research Group. Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11. Ophthalmology. 1991b;98(5 Suppl):807–22.

    Google Scholar 

  • ETDRS Research Group. Effects of aspirin treatment on diabetic retinopathy. ETDRS report number 8. Ophthalmology. 1991c;98(5 Suppl):757–65.

    Google Scholar 

  • ETDRS Research Group . Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Ophthalmology. 1991;98(5 Suppl):823–33.

    Google Scholar 

  • ETDRS Research Group. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Arch Ophthalmol. 1995;113(9):1144–55.

    Article  Google Scholar 

  • Evans JR, Michelessi M, Virgili G. Laser photocoagulation for proliferative diabetic retinopathy. Cochrane Database Syst Rev. 2014;11:CD011234.

    PubMed  Google Scholar 

  • Ferrannini E, Cushman WC. Diabetes and hypertension: the bad companions. Lancet. 2012;380(9841):601–10.

    Article  PubMed  Google Scholar 

  • Ferris III FL. How effective are treatments for diabetic retinopathy? JAMA. 1993;269(10):1290–1.

    Article  PubMed  Google Scholar 

  • Ferris F. Early photocoagulation in patients with either type I or type II diabetes. Trans Am Ophthalmol Soc. 1996;94:505–37.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Fialho SL, Rego MB, Siqueira RC, et al. Safety and pharmacokinetics of an intravitreal biodegradable implant of dexamethasone acetate in rabbit eyes. Curr Eye Res. 2006;31(6):525–34.

    Article  CAS  PubMed  Google Scholar 

  • Figueira J, Khan J, Nunes S, et al. Prospective randomised controlled trial comparing sub-threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema. Br J Ophthalmol. 2009;93(10):1341–4.

    Article  CAS  PubMed  Google Scholar 

  • Finger RP, Fimmers R, Holz FG, et al. Incidence of blindness and severe visual impairment in Germany: projections for 2030. Invest Ophthalmol Vis Sci. 2011;52(7):4381–9.

    Article  PubMed  Google Scholar 

  • Fiore T, Androudi S, Iaccheri B, et al. Repeatability and reproducibility of retinal thickness measurements in diabetic patients with spectral domain optical coherence tomography. Curr Eye Res. 2013;38(6):674–9.

    Article  PubMed  Google Scholar 

  • Flaxel CJ, Edwards AR, Aiello LP, et al. Factors associated with visual acuity outcomes after vitrectomy for diabetic macular edema: diabetic retinopathy clinical research network. Retina. 2010;30(9):1488–95.

    Article  PubMed  Google Scholar 

  • Fonda SJ, Bursell SE, Lewis DG, et al. The relationship of a diabetes telehealth eye care program to standard eye care and change in diabetes health outcomes. Telemed JE Health. 2007;13(6):635–44.

    Article  Google Scholar 

  • Fong DS, Ferris III FL, Davis MD, et al. Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no. 24. Early Treatment Diabetic Retinopathy Study Research Group. Am J Ophthalmol. 1999;127(2):137–41.

    Article  CAS  PubMed  Google Scholar 

  • Fong DS, Gottlieb J, Ferris III FL, et al. Understanding the value of diabetic retinopathy screening. Arch Ophthalmol. 2001;119(5):758–60.

    Article  CAS  PubMed  Google Scholar 

  • Fong DS, Strauber SF, Aiello LP, et al. Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch Ophthalmol. 2007;125(4):469–80.

    Article  PubMed  Google Scholar 

  • Fortun JA, Hubbard III GB. New viscodissection instrument for use with microincisional vitrectomy in the treatment of diabetic tractional retinal detachments. Arch Ophthalmol. 2011;129(3):352–5.

    Article  PubMed  Google Scholar 

  • Framme C, Walter A, Prahs P, et al. Structural changes of the retina after conventional laser photocoagulation and selective retina treatment (SRT) in spectral domain OCT. Curr Eye Res. 2009;34(7):568–79.

    Article  PubMed  Google Scholar 

  • Frank RN. Systemic therapies for diabetic retinopathy: the accord eye study. Ophthalmology. 2014;121(12):2295–6.

    Article  PubMed  Google Scholar 

  • Friberg TR, Karatza EC. The treatment of macular disease using a micropulsed and continuous wave 810-nm diode laser. Ophthalmology. 1997;104(12):2030–8.

    Article  CAS  PubMed  Google Scholar 

  • Frier BM. Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications. Nat Rev Endocrinol. 2014;10(12):711–22.

    Article  CAS  PubMed  Google Scholar 

  • Fullerton B, Jeitler K, Seitz M, et al. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2014;2:CD009122.

    PubMed  Google Scholar 

  • Funatsu H, Noma H, Mimura T, et al. Association of vitreous inflammatory factors with diabetic macular edema. Ophthalmology. 2009;116(1):73–9.

    Article  PubMed  Google Scholar 

  • Garay-Sevilla ME, Porras JS, Malacara JM. Coping strategies and adherence to treatment in patients with type 2 diabetes mellitus. Rev Invest Clin. 2011;63(2):155–61.

    PubMed  Google Scholar 

  • Gardner TW, Antonetti DA, Barber AJ, et al. Diabetic retinopathy: more than meets the eye. Surv Ophthalmol. 2002;47 Suppl 2:S253–62.

    Article  PubMed  Google Scholar 

  • Ghazi NG, Ciralsky JB, Shah SM, et al. Optical coherence tomography findings in persistent diabetic macular edema: the vitreomacular interface. Am J Ophthalmol. 2007;144(5):747–54.

    Article  PubMed  Google Scholar 

  • Gillies MC, Lim LL, Campain A, et al. A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study. Ophthalmology. 2014;121(12):2473–81.

    Article  PubMed  Google Scholar 

  • Giovannini A, Amato GP, Mariotti C, et al. Diabetic maculopathy induced by vitreo-macular traction: evaluation by optical coherence tomography (OCT). Doc Ophthalmol. 1999;97(3–4):361–6.

    Article  CAS  PubMed  Google Scholar 

  • Goatman KA, Cree MJ, Olson JA, et al. Automated measurement of microaneurysm turnover. Invest Ophthalmol Vis Sci. 2003;44(12):5335–41.

    Article  PubMed  Google Scholar 

  • Grassi MA, Tikhomirov A, Ramalingam S, et al. Replication analysis for severe diabetic retinopathy. Invest Ophthalmol Vis Sci. 2012;53(4):2377–81.

    Article  PubMed  PubMed Central  Google Scholar 

  • Grunwald JE, Pistilli M, Ying GS, et al. Retinopathy and progression of CKD: The CRIC study. Clin J Am Soc Nephrol. 2014;9(7):1217–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971–1993. Diabetes Care. 1998;21(7):1138–45.

    Article  CAS  PubMed  Google Scholar 

  • Guigou S, Hajjar C, Parrat E, et al. Multicenter Ozurdex(R) assessment for diabetic macular edema: MOZART study. J Fr Ophtalmol. 2014;37(6):480–5.

    Article  CAS  PubMed  Google Scholar 

  • Gulliford MC, Dodhia H, Chamley M, et al. Socio-economic and ethnic inequalities in diabetes retinal screening. Diabet Med. 2010;27(3):282–8.

    Article  CAS  PubMed  Google Scholar 

  • Gunderson EP, Lewis CE, Tsai AL, et al. A 20-year prospective study of childbearing and incidence of diabetes in young women, controlling for glycemia before conception: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Diabetes. 2007;56(12):2990–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gunduz K, Bakri SJ. Management of proliferative diabetic retinopathy. Compr Ophthalmol Update. 2007;8(5):245–56.

    PubMed  Google Scholar 

  • Gupta B, Sivaprasad S, Wong R, et al. Visual and anatomical outcomes following vitrectomy for complications of diabetic retinopathy: the DRIVE UK study. Eye (Lond). 2012;26(4):510–6.

    Article  CAS  Google Scholar 

  • Haller JA, Qin H, Apte RS, et al. Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology. 2010;117(6):1087–93.

    Article  PubMed  Google Scholar 

  • Hammes HP, Feng Y, Pfister F, et al. Diabetic retinopathy: targeting vasoregression. Diabetes. 2011a;60(1):|9–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hammes HP, Kerner W, Hofer S, et al. Diabetic retinopathy in type 1 diabetes-a contemporary analysis of 8,784 patients. Diabetologia. 2011b;54(8):1977–84.

    Article  CAS  PubMed  Google Scholar 

  • Hayes AJ, Leal J, Gray AM, et al. UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82. Diabetologia. 2013;56(9):1925–33.

    Article  CAS  PubMed  Google Scholar 

  • Hayreh SS. Neovascular glaucoma. Prog Retin Eye Res. 2007;26(5):470–85.

    Article  PubMed  PubMed Central  Google Scholar 

  • Heintz E, Wirehn AB, Peebo BB, et al. Prevalence and healthcare costs of diabetic retinopathy: a population-based register study in Sweden. Diabetologia. 2010;53(10):2147–54.

    Article  CAS  PubMed  Google Scholar 

  • Helbig H. Surgery for diabetic retinopathy. Ophthalmologica. 2007;221(2):103–11.

    Article  PubMed  Google Scholar 

  • Hellstedt T, Vesti E, Immonen I. Identification of individual microaneurysms: a comparison between fluorescein angiograms and red-free and colour photographs. Graefes Arch Clin Exp Ophthalmol. 1996;234 Suppl 1:S13–7.

    Article  PubMed  Google Scholar 

  • Hellstedt T, Kaaja R, Teramo K, et al. The effect of pregnancy on mild diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 1997;235(7):437–41.

    Article  CAS  PubMed  Google Scholar 

  • Hemmingsen B, Lund SS, Gluud C, et al. Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials. BMJ. 2011;343:d6898.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hietala K, Harjutsalo V, Forsblom C, et al. Age at onset and the risk of proliferative retinopathy in type 1 diabetes. Diabetes Care. 2010;33(6):1315–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Huang OS, Tay WT, Tai ES, et al. Lack of awareness amongst community patients with diabetes and diabetic retinopathy: the Singapore Malay eye study. Ann Acad Med Singapore. 2009;38(12):1048–55.

    PubMed  Google Scholar 

  • Hugenschmidt CE, Lovato JF, Ambrosius WT, et al. The cross-sectional and longitudinal associations of diabetic retinopathy with cognitive function and brain MRI findings: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care. 2014;37(12):3244–52.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hutchins E, Coppell KJ, Morris A, et al. Diabetic retinopathy screening in New Zealand requires improvement: results from a multi-centre audit. Aust N Z J Public Health. 2012;36(3):257–62.

    Article  PubMed  Google Scholar 

  • Imai M, Iijima H, Hanada N. Optical coherence tomography of tractional macular elevations in eyes with proliferative diabetic retinopathy. Am J Ophthalmol. 2001;132(3):458–61.

    Article  CAS  PubMed  Google Scholar 

  • Inchiostro S, Candido R, Cavalot F. How can we monitor glycaemic variability in the clinical setting? Diabetes Obes Metab. 2013;15 Suppl 2:13–6.

    Article  CAS  PubMed  Google Scholar 

  • Ip MS, Domalpally A, Sun JK, et al. Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy. Ophthalmology. 2015;122(2):367–74.

    Article  PubMed  Google Scholar 

  • Ishibashi T, Li X, Koh A, et al. The REVEAL Study: ranibizumab monotherapy or combined with laser versus laser monotherapy in Asian patients with diabetic macular edema. Ophthalmology. 2015;122:1402–15.

    Article  PubMed  Google Scholar 

  • Ishida S, Usui T, Yamashiro K, et al. VEGF164 is proinflammatory in the diabetic retina. Invest Ophthalmol Vis Sci. 2003;44(5):2155–62.

    Article  PubMed  Google Scholar 

  • Ito H, Horii T, Nishijima K, et al. Association between fluorescein leakage and optical coherence tomographic characteristics of microaneurysms in diabetic retinopathy. Retina. 2013;33(4):732–9.

    Article  PubMed  Google Scholar 

  • Jackson TL, Nicod E, Angelis A, et al. Vitreous attachment in age-related macular degeneration, diabetic macular edema, and retinal vein occlusion: a systematic review and metaanalysis. Retina. 2013;33(6):1099–108.

    Article  PubMed  Google Scholar 

  • Jacobson DR, Murphy RP, Rosenthal AR. The treatment of angle neovascularization with panretinal photocoagulation. Ophthalmology. 1979;86(7):1270–7.

    Article  CAS  PubMed  Google Scholar 

  • Jaissle GB, Szurman P, Bartz-Schmidt KU. Ocular side effects and complications of intravitreal triamcinolone acetonide injection. Ophthalmologe. 2004;101(2):121–8.

    Article  CAS  PubMed  Google Scholar 

  • Jalli PY, Hellstedt TJ, Immonen IJ. Early versus late staining of microaneurysms in fluorescein angiography. Retina. 1997;17(3):211–5.

    Article  CAS  PubMed  Google Scholar 

  • Javitt JC, Aiello LP. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med. 1996;124(1 Pt 2):164–9.

    Article  CAS  PubMed  Google Scholar 

  • Kahn HA, Hiller R. Blindness caused by diabetic retinopathy. Am J Ophthalmol. 1974;78(1):58–67.

    Article  CAS  PubMed  Google Scholar 

  • Kamoi K, Takeda K, Hashimoto K, et al. Identifying risk factors for clinically significant diabetic macula edema in patients with type 2 diabetes mellitus. Curr Diabetes Rev. 2013;9(3):209–17.

    Article  PubMed  Google Scholar 

  • Kampik A, Kenyon KR, Michels RG, et al. Epiretinal and vitreous membranes. Comparative study of 56 cases. Arch Ophthalmol. 1981;99(8):1445–54.

    Article  CAS  PubMed  Google Scholar 

  • Kandarakis SA, Piperi C, Topouzis F, et al. Emerging role of advanced glycation-end products (AGEs) in the pathobiology of eye diseases. Prog Retin Eye Res. 2014;42:85–102.

    Article  CAS  PubMed  Google Scholar 

  • Kane FE, Burdan J, Cutino A, et al. Iluvien: a new sustained delivery technology for posterior eye disease. Expert Opin Drug Deliv. 2008;5(9):1039–46.

    Article  CAS  PubMed  Google Scholar 

  • Kang H, Su L, Zhang H, et al. Early histological alteration of the retina following photocoagulation treatment in diabetic retinopathy as measured by spectral domain optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2010;248(12):1705–11.

    Article  PubMed  Google Scholar 

  • Karam JG, McFarlane SI. Update on the prevention of type 2 diabetes. Curr Diab Rep. 2011;11(1):56–63.

    Article  PubMed  Google Scholar 

  • Kaul K, Hodgkinson A, Tarr JM, et al. Is inflammation a common retinal-renal-nerve pathogenic link in diabetes? Curr Diabetes Rev. 2010;6(5):294–303.

    Article  CAS  PubMed  Google Scholar 

  • Keech AC, Mitchell P, Summanen PA, et al. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet. 2007;370(9600):1687–97.

    Article  CAS  PubMed  Google Scholar 

  • Kempen JH, O’Colmain BJ, Leske MC, et al. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122(4):552–63.

    Article  PubMed  Google Scholar 

  • Kern TS. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res. 2007;2007:95103.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Kern TS, Engerman RL. A mouse model of diabetic retinopathy. Arch Ophthalmol. 1996;114(8):986–90.

    Article  CAS  PubMed  Google Scholar 

  • Khalaf SS, Al-Bdour MD, Al-Till MI. Clinical biomicroscopy versus fluorescein angiography: effectiveness and sensitivity in detecting diabetic retinopathy. Eur J Ophthalmol. 2007;17(1):84–8.

    CAS  PubMed  Google Scholar 

  • Khan MA, Haller JA. Clinical management of vitreomacular traction. Curr Opin Ophthalmol. 2015;26(3):143–8.

    Article  PubMed  Google Scholar 

  • Kiddee W, Trope GE, Sheng L, et al. Intraocular pressure monitoring post intravitreal steroids: a systematic review. Surv Ophthalmol. 2013;58(4):291–310.

    Article  PubMed  Google Scholar 

  • Kiire CA, Porta M, Chong V. Medical management for the prevention and treatment of diabetic macular edema. Surv Ophthalmol. 2013;58(5):459–65.

    Article  PubMed  Google Scholar 

  • Klaassen I, Van Noorden CJ, Schlingemann RO. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions. Prog Retin Eye Res. 2013;34:19–48.

    Article  CAS  PubMed  Google Scholar 

  • Klein R. Screening interval for retinopathy in type 2 diabetes. Lancet. 2003;361(9353):190–1.

    Article  PubMed  Google Scholar 

  • Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984;102(4):520–6.

    Article  CAS  PubMed  Google Scholar 

  • Klein BE, Moss SE, Klein R. Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care. 1990;13(1):34–40.

    Article  CAS  PubMed  Google Scholar 

  • Klein R, Klein BE, Moss SE. Epidemiology of proliferative diabetic retinopathy. Diabetes Care. 1992;15(12):1875–91.

    Article  CAS  PubMed  Google Scholar 

  • Klein BE, Klein R, Lee KE. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care. 2002;25(10):1790–4.

    Article  PubMed  Google Scholar 

  • Klein R, Knudtson MD, Lee KE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. Ophthalmology. 2009;116(3):497–503.

    Article  PubMed  PubMed Central  Google Scholar 

  • Klein R, Lee KE, Gangnon RE, et al. Relation of smoking, drinking, and physical activity to changes in vision over a 20-year period: the Beaver Dam Eye Study. Ophthalmology. 2014;121(6):1220–8.

    Article  PubMed  PubMed Central  Google Scholar 

  • Klein BE, Myers CE, Howard KP, et al. Serum lipids and proliferative diabetic retinopathy and macular edema in persons with long-term type 1 diabetes mellitus: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. JAMA Ophthalmol. 2015;133:503–10.

    Article  PubMed  PubMed Central  Google Scholar 

  • Klonoff DC, Schwartz DM. An economic analysis of interventions for diabetes. Diabetes Care. 2000;23(3):390–404.

    Article  CAS  PubMed  Google Scholar 

  • Kohner EM, Henkind P. Correlation of fluorescein angiogram and retinal digest in diabetic retinopathy. Am J Ophthalmol. 1970;69(3):403–14.

    Article  CAS  PubMed  Google Scholar 

  • Kohner EM, Stratton IM, Aldington SJ, et al. Relationship between the severity of retinopathy and progression to photocoagulation in patients with type 2 diabetes mellitus in the UKPDS (UKPDS 52). Diabet Med. 2001;18(3):178–84.

    Article  CAS  PubMed  Google Scholar 

  • Korobelnik JF, Do DV, Schmidt-Erfurth U, et al. Intravitreal aflibercept for diabetic macular edema. Ophthalmology. 2014;121(11):2247–54.

    Article  PubMed  Google Scholar 

  • Kozak I, Oster SF, Cortes MA, et al. Clinical evaluation and treatment accuracy in diabetic macular edema using navigated laser photocoagulator NAVILAS. Ophthalmology. 2011;118(6):1119–24.

    Article  PubMed  Google Scholar 

  • Kozak I, El-Emam SY, Cheng L, et al. Fluorescein angiography versus optical coherence tomography-guided planning for macular laser photocoagulation in diabetic macular edema. Retina. 2014;34(8):1600–5.

    Article  PubMed  PubMed Central  Google Scholar 

  • Kristinsson JK, Gudmundsson JR, Stefansson E, et al. Screening for diabetic retinopathy. Initiation and frequency. Acta Ophthalmol Scand. 1995;73(6):525–8.

    Article  CAS  PubMed  Google Scholar 

  • Kumagai K, Furukawa M, Ogino N, et al. Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema. Retina. 2009;29(4):464–72.

    Article  PubMed  Google Scholar 

  • Kumar A, Duraipandi K, Gogia V, et al. Comparative evaluation of 23- and 25-gauge microincision vitrectomy surgery in management of diabetic macular traction retinal detachment. Eur J Ophthalmol. 2014;24(1):107–13.

    Article  PubMed  Google Scholar 

  • Kuppermann BD, Blumenkranz MS, Haller JA, et al. Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol. 2007;125(3):309–17.

    Article  CAS  PubMed  Google Scholar 

  • Laidlaw DA. Vitrectomy for diabetic macular oedema. Eye (Lond). 2008;22(10):1337–41.

    Article  CAS  Google Scholar 

  • Lang GE. Diabetic macular edema. Ophthalmologica. 2012;227 Suppl 1:21–9.

    Article  CAS  PubMed  Google Scholar 

  • Lang GE. Mechanisms of retinal neurodegeneration as a result of diabetes mellitus. Klin Monbl Augenheilkd. 2013;230(9):929–31.

    Article  CAS  PubMed  Google Scholar 

  • Lauszus FF, Klebe JG, Bek T, et al. Increased serum IGF-I during pregnancy is associated with progression of diabetic retinopathy. Diabetes. 2003;52(3):852–6.

    Article  CAS  PubMed  Google Scholar 

  • LeCaire TJ, Palta M, Klein R, et al. Assessing progress in retinopathy outcomes in type 1 diabetes: comparing findings from the Wisconsin Diabetes Registry Study and the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care. 2013;36(3):631–7.

    Article  PubMed  PubMed Central  Google Scholar 

  • Lee CM, Olk RJ. Modified grid laser photocoagulation for diffuse diabetic macular edema. Long-term visual results. Ophthalmology. 1991;98(10):1594–602.

    Article  CAS  PubMed  Google Scholar 

  • Lee WJ, Sobrin L, Kang MH, et al. Ischemic diabetic retinopathy as a possible prognostic factor for chronic kidney disease progression. Eye (Lond). 2014;28(9):1119–25.

    Article  CAS  Google Scholar 

  • Leicht SF, Kernt M, Neubauer A, et al. Microaneurysm turnover in diabetic retinopathy assessed by automated RetmarkerDR image analysis—potential role as biomarker of response to ranibizumab treatment. Ophthalmologica. 2014;231(4):198–203.

    Article  CAS  PubMed  Google Scholar 

  • Li CS, Neu MB, Shaw LC, et al. EPCs and pathological angiogenesis: when good cells go bad. Microvasc Res. 2010;79(3):207–16.

    Article  CAS  Google Scholar 

  • Li LX, Li MF, Lu JX, et al. Retinal microvascular abnormalities are associated with early carotid atherosclerotic lesions in hospitalized Chinese patients with type 2 diabetes mellitus. J Diabetes Complications. 2014;28(3):378–85.

    Article  PubMed  Google Scholar 

  • Liegl R, Langer J, Seidensticker F, et al. Comparative evaluation of combined navigated laser photocoagulation and intravitreal ranibizumab in the treatment of diabetic macular edema. PLoS One. 2014;9(12):e113981.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Lim LS, Cheung CM, Mitchell P, et al. Emerging evidence concerning systemic safety of anti-VEGF agents—should ophthalmologists be concerned? Am J Ophthalmol. 2011;152(3):329–31.

    Article  PubMed  Google Scholar 

  • Liu L, Wu X, Liu L, et al. Prevalence of diabetic retinopathy in mainland China: a meta-analysis. PLoS One. 2012;7(9):e45264.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liu H, Zhang W, Xu Z, et al. Hyperoxia causes regression of vitreous neovascularization by downregulating VEGF/VEGFR2 pathway. Invest Ophthalmol Vis Sci. 2013;54(2):918–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lombardo M, Parravano M, Serrao S, et al. Analysis of retinal capillaries in patients with type 1 diabetes and nonproliferative diabetic retinopathy using adaptive optics imaging. Retina. 2013;33(8):1630–9.

    Article  PubMed  Google Scholar 

  • Looker HC, Nyangoma SO, Cromie DT, et al. Rates of referable eye disease in the Scottish National Diabetic Retinopathy Screening Programme. Br J Ophthalmol. 2014;98(6):790–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Loprinzi PD, Brodowicz GR, Sengupta S, et al. Accelerometer-assessed physical activity and diabetic retinopathy in the United States. JAMA Ophthalmol. 2014;132(8):1017–9.

    Article  PubMed  Google Scholar 

  • Loukovaara S, Harju M, Kaaja R, et al. Retinal capillary blood flow in diabetic and nondiabetic women during pregnancy and postpartum period. Invest Ophthalmol Vis Sci. 2003;44(4):1486–91.

    Article  PubMed  Google Scholar 

  • Lovestam-Adrian M, Agardh E. Photocoagulation of diabetic macular oedema—complications and visual outcome. Acta Ophthalmol Scand. 2000;78(6):667–71.

    Article  CAS  PubMed  Google Scholar 

  • Luke J, Nassar K, Luke M, et al. Ranibizumab as adjuvant in the treatment of rubeosis iridis and neovascular glaucoma—results from a prospective interventional case series. Graefes Arch Clin Exp Ophthalmol. 2013;251(10):2403–13.

    Article  PubMed  CAS  Google Scholar 

  • Lung JC, Swann PG, Chan HH. Early local functional changes in the human diabetic retina: a global flash multifocal electroretinogram study. Graefes Arch Clin Exp Ophthalmol. 2012;250(12):1745–54.

    Article  PubMed  Google Scholar 

  • Luo D, Zheng Z, Xu X, et al. Systematic review of various laser intervention strategies for proliferative diabetic retinopathy. Expert Rev Med Devices. 2015;12(1):83–91.

    Article  CAS  PubMed  Google Scholar 

  • Lutty GA. Effects of diabetes on the eye. Invest Ophthalmol Vis Sci. 2013;54(14):ORSF81–7.

    Article  PubMed  PubMed Central  Google Scholar 

  • Ly A, Scheerer MF, Zukunft S, et al. Retinal proteome alterations in a mouse model of type 2 diabetes. Diabetologia. 2014;57(1):192–203.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Maberley DA, Koushik A, Cruess AF. Factors associated with missed eye examinations in a cohort with diabetes. Can J Public Health. 2002;93(3):229–32.

    PubMed  Google Scholar 

  • Maclennan PA, McGwin Jr G, Heckemeyer C, et al. Eye care use among a high-risk diabetic population seen in a public hospital’s clinics. JAMA Ophthalmol. 2014;132(2):162–7.

    Article  PubMed  PubMed Central  Google Scholar 

  • Madsen-Bouterse SA, Kowluru RA. Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Rev Endocr Metab Disord. 2008;9(4):315–27.

    Article  CAS  PubMed  Google Scholar 

  • Maeshima K, Utsugi-Sutoh N, Otani T, et al. Progressive enlargement of scattered photocoagulation scars in diabetic retinopathy. Retina. 2004;24(4):507–11.

    Article  PubMed  Google Scholar 

  • Maheshwary AS, Oster SF, Yuson RM, et al. The association between percent disruption of the photoreceptor inner segment-outer segment junction and visual acuity in diabetic macular edema. Am J Ophthalmol. 2010;150(1):63–7.

    Article  PubMed  PubMed Central  Google Scholar 

  • Marticorena J, Romano V, Gomez-Ulla F. Sterile endophthalmitis after intravitreal injections. Mediators Inflamm. 2012;2012:928123.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Martinez-Zapata MJ, Marti-Carvajal AJ, Sola I, et al. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy. Cochrane Database Syst Rev. 2014;11:CD008721.

    PubMed  Google Scholar 

  • Massin P, Peto T, Ansquer JC, et al. Effects of fenofibric acid on diabetic macular edema: the MacuFen study. Ophthalmic Epidemiol. 2014;21(5):307–17.

    Article  PubMed  Google Scholar 

  • Matsuda S, Tam T, Singh RP, et al. Impact of insulin treatment in diabetic macular edema therapy in type 2 diabetes. Can J Diabetes. 2015;39(1):73–7.

    Article  PubMed  PubMed Central  Google Scholar 

  • Matsuo T. Disappearance of diabetic macular hard exudates after hemodialysis introduction. Acta Med Okayama. 2006;60(3):201–5.

    PubMed  Google Scholar 

  • Matsuoka M, Ogata N, Minamino K, et al. Leukostasis and pigment epithelium-derived factor in rat models of diabetic retinopathy. Mol Vis. 2007;13:1058–65.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Mazhar K, Varma R, Choudhury F, et al. Severity of diabetic retinopathy and health-related quality of life: the Los Angeles Latino Eye Study. Ophthalmology. 2011;118(4):649–55.

    Article  PubMed  PubMed Central  Google Scholar 

  • Mehlsen J, Erlandsen M, Poulsen PL, et al. Individualized optimization of the screening interval for diabetic retinopathy: a new model. Acta Ophthalmol. 2012;90(2):109–14.

    Article  PubMed  Google Scholar 

  • Messenger WB, Beardsley RM, Flaxel CJ. Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema. Drug Des Devel Ther. 2013;7:425–34.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Meyer-Schwickerath G. Historical perspective of photocoagulation (in retinal vascular diseases). Doc Ophthalmol. 1977;44(1):77–9.

    Article  CAS  PubMed  Google Scholar 

  • Miller JW, Le CJ, Strauss EC, et al. Vascular endothelial growth factor a in intraocular vascular disease. Ophthalmology. 2013;120(1):106–14.

    Article  PubMed  Google Scholar 

  • Misra A, Bachmann MO, Greenwood RH, et al. Trends in yield and effects of screening intervals during 17 years of a large UK community-based diabetic retinopathy screening programme. Diabet Med. 2009;26(10):1040–7.

    Article  CAS  PubMed  Google Scholar 

  • Mitchell P, Bandello F, Schmidt-Erfurth U, et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology. 2011;118(4):615–25.

    Article  PubMed  Google Scholar 

  • Moss SE, Klein R, Klein BE. Ten-year incidence of visual loss in a diabetic population. Ophthalmology. 1994;101(6):1061–70.

    Article  CAS  PubMed  Google Scholar 

  • Murakami T, Uji A, Ogino K, et al. Association between perifoveal hyperfluorescence and serous retinal detachment in diabetic macular edema. Ophthalmology. 2013;120(12):2596–603.

    Article  PubMed  Google Scholar 

  • Nam S, Chesla C, Stotts NA, et al. Barriers to diabetes management: patient and provider factors. Diabetes Res Clin Pract. 2011;93(1):1–9.

    Article  PubMed  Google Scholar 

  • Narayan KM, Boyle JP, Thompson TJ, et al. Lifetime risk for diabetes mellitus in the United States. JAMA. 2003;290(14):1884–90.

    Article  CAS  PubMed  Google Scholar 

  • Narayan KM, Boyle JP, Thompson TJ, et al. Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care. 2007;30(6):1562–6.

    Article  CAS  PubMed  Google Scholar 

  • Navarro A, Pournaras JA, Hoffart L, et al. Vitrectomy may prevent the occurrence of diabetic macular oedema. Acta Ophthalmol. 2010;88(4):483–5.

    Article  PubMed  Google Scholar 

  • Nawaz MI, Van RK, Mohammad G, et al. Autocrine CCL2, CXCL4, CXCL9 and CXCL10 signal in retinal endothelial cells and are enhanced in diabetic retinopathy. Exp Eye Res. 2013;109:67–76.

    Article  CAS  PubMed  Google Scholar 

  • Nehme A, Edelman J. Dexamethasone inhibits high glucose-, TNF-alpha-, and IL-1beta-induced secretion of inflammatory and angiogenic mediators from retinal microvascular pericytes. Invest Ophthalmol Vis Sci. 2008;49(5):2030–8.

    Article  PubMed  Google Scholar 

  • Neubauer AS, Langer J, Liegl R, et al. Navigated macular laser decreases retreatment rate for diabetic macular edema: a comparison with conventional macular laser. Clin Ophthalmol. 2013;7:121–8.

    PubMed  PubMed Central  Google Scholar 

  • Nguyen QD, Brown DM, Marcus DM, et al. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology. 2012;119(4):789–801.

    Article  PubMed  Google Scholar 

  • Nguyen-Khoa BA, Goehring EL, Werther W, et al. Hospitalized cardiovascular events in patients with diabetic macular edema. BMC Ophthalmol. 2012;12:11.

    Article  PubMed  PubMed Central  Google Scholar 

  • Nielsen LR, Pedersen-Bjergaard U, Thorsteinsson B, et al. Hypoglycemia in pregnant women with type 1 diabetes: predictors and role of metabolic control. Diabetes Care. 2008;31(1):9–14.

    Article  PubMed  Google Scholar 

  • Nisic F, Turkovic S, Mavija M, et al. Correlation between the findings of optical coherent retinal tomography (OCT), stereo biomicroscopic images from fundus of an eye and values from visual acuity of diabetic macular edema. Acta Inform Med. 2014;22(4):232–6.

    Article  PubMed  PubMed Central  Google Scholar 

  • Nunes S, Pires I, Rosa A, et al. Microaneurysm turnover is a biomarker for diabetic retinopathy progression to clinically significant macular edema: findings for type 2 diabetics with nonproliferative retinopathy. Ophthalmologica. 2009;223(5):292–7.

    Article  PubMed  Google Scholar 

  • Ogata N, Tombran-Tink J, Jo N, et al. Upregulation of pigment epithelium-derived factor after laser photocoagulation. Am J Ophthalmol. 2001;132(3):427–9.

    Article  CAS  PubMed  Google Scholar 

  • Ola MS, Nawaz MI, Siddiquei MM, et al. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy. J Diabetes Complications. 2012;26(1):56–64.

    Article  PubMed  Google Scholar 

  • Olsen TW, Adelman RA, Flaxel CJ, et al. Preferred practice pattern diabetic retinopathy. Am Acad Ophthalmol. 2014.

    Google Scholar 

  • Ophir A. Full-field 3-D optical coherence tomography imaging and treatment decision in diffuse diabetic macular edema. Invest Ophthalmol Vis Sci. 2014;55(5):3052–3.

    Article  PubMed  Google Scholar 

  • Ophir A, Trevino A, Fatum S. Extrafoveal vitreous traction associated with diabetic diffuse macular oedema. Eye (Lond). 2010;24(2):347–53.

    Article  CAS  Google Scholar 

  • Ostri C, Lux A, Lund-Andersen H, et al. Long-term results, prognostic factors and cataract surgery after diabetic vitrectomy: a 10-year follow-up study. Acta Ophthalmol. 2014;92(6):571–6.

    Article  PubMed  Google Scholar 

  • Palermo A, Maggi D, Maurizi AR, et al. Prevention of type 2 diabetes mellitus: is it feasible? Diabetes Metab Res Rev. 2014;30 Suppl 1:4–12.

    Article  PubMed  Google Scholar 

  • Panozzo G, Parolini B, Gusson E, et al. Diabetic macular edema: an OCT-based classification. Semin Ophthalmol. 2004;19(1–2):13–20.

    Article  CAS  PubMed  Google Scholar 

  • Park JH, Woo SJ, Ha YJ, et al. Effect of vitrectomy on macular microcirculation in patients with diffuse diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2009;247(8):1009–17.

    Article  PubMed  Google Scholar 

  • Park YG, Kim EY, Roh YJ. Laser-based strategies to treat diabetic macular edema: history and new promising therapies. J Ophthalmol. 2014;2014:769213.

    Article  PubMed  PubMed Central  Google Scholar 

  • Parravano M, Menchini F, Virgili G. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema. Cochrane Database Syst Rev. 2009;4:CD007419.

    PubMed  Google Scholar 

  • Patel JI, Hykin PG, Schadt M, et al. Pars plana vitrectomy with and without peeling of the inner limiting membrane for diabetic macular edema. Retina. 2006;26(1):5–13.

    Article  PubMed  Google Scholar 

  • Paz SH, Varma R, Klein R, et al. Noncompliance with vision care guidelines in Latinos with type 2 diabetes mellitus: the Los Angeles Latino Eye Study. Ophthalmology. 2006;113(8):1372–7.

    Article  PubMed  Google Scholar 

  • Pearce E, Sivaprasad S, Chong NV. Factors affecting reading speed in patients with diabetic macular edema treated with laser photocoagulation. PLoS One. 2014;9(9):e105696.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Pearson PA, Comstock TL, Ip M, et al. Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial. Ophthalmology. 2011;118(8):1580–7.

    Article  PubMed  Google Scholar 

  • Pei-Pei W, Shi-Zhou H, Zhen T, et al. Randomised clinical trial evaluating best-corrected visual acuity and central macular thickness after 532-nm subthreshold laser grid photocoagulation treatment in diabetic macular oedema. Eye (Lond). 2015;29(3):313–22.

    Article  CAS  Google Scholar 

  • Pelletier EM, Shim B, Ben-Joseph R, et al. Economic outcomes associated with microvascular complications of type 2 diabetes mellitus: results from a US claims data analysis. Pharmacoeconomics. 2009;27(6):479–90.

    Article  PubMed  Google Scholar 

  • Perreault L, Pan Q, Mather KJ, et al. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet. 2012;379(9833):2243–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pershing S, Enns EA, Matesic B, et al. Cost-effectiveness of treatment of diabetic macular edema. Ann Intern Med. 2014;160(1):18–29.

    Article  PubMed  PubMed Central  Google Scholar 

  • Pfeiffer A, Spranger J, Meyer-Schwickerath R, et al. Growth factor alterations in advanced diabetic retinopathy: a possible role of blood retina barrier breakdown. Diabetes. 1997;46 Suppl 2:S26–30.

    Article  CAS  PubMed  Google Scholar 

  • Phelps RL, Sakol P, Metzger BE, et al. Changes in diabetic retinopathy during pregnancy. Correlations with regulation of hyperglycemia. Arch Ophthalmol. 1986;104(12):1806–10.

    Article  CAS  PubMed  Google Scholar 

  • Pires I, Santos AR, Nunes S, et al. Subclinical macular edema as a predictor of progression to clinically significant macular edema in type 2 diabetes. Ophthalmologica. 2013;230(4):201–6.

    Article  CAS  PubMed  Google Scholar 

  • Pokroy R, Desai UR, Du E, et al. Bevacizumab prior to vitrectomy for diabetic traction retinal detachment. Eye (Lond). 2011;25(8):989–97.

    Article  CAS  Google Scholar 

  • Qi HP, Bi S, Wei SQ, et al. Intravitreal versus subtenon triamcinolone acetonide injection for diabetic macular edema: a systematic review and meta-analysis. Curr Eye Res. 2012;37(12):1136–47.

    Article  CAS  PubMed  Google Scholar 

  • Qiao Q, Keinanen-Kiukaanniemi S, Laara E. The relationship between hemoglobin levels and diabetic retinopathy. J Clin Epidemiol. 1997;50(2):153–8.

    Article  CAS  PubMed  Google Scholar 

  • Rahman W, Rahman FZ, Yassin S, et al. Progression of retinopathy during pregnancy in type 1 diabetes mellitus. Clin Experiment Ophthalmol. 2007;35(3):231–6.

    Article  PubMed  Google Scholar 

  • Rajendram R, Fraser-Bell S, Kaines A, et al. A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3. Arch Ophthalmol. 2012;130(8):972–9.

    Article  CAS  PubMed  Google Scholar 

  • Rangasamy S, McGuire PG, Franco NC, et al. Chemokine mediated monocyte trafficking into the retina: role of inflammation in alteration of the blood-retinal barrier in diabetic retinopathy. PLoS One. 2014;9(10):e108508.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Rasmussen KL, Laugesen CS, Ringholm L, et al. Progression of diabetic retinopathy during pregnancy in women with type 2 diabetes. Diabetologia. 2010;53(6):1076–83.

    Article  CAS  PubMed  Google Scholar 

  • Raum P, Peto T, Pfeiffer N, Wild P, Hoehn R, Ponto K, Schneider A, Schulz A, Lamparter J, Mirshahi A. Prevalence and cardiovascular risk factors of diabetic retinopathy: results from the Gutenberg Health Study. Invest Ophthalmol Vis Sci. 2014;55:5339 (Abstract).

    Google Scholar 

  • Regnier S, Malcolm W, Allen F, et al. Efficacy of anti-VEGF and laser photocoagulation in the treatment of visual impairment due to diabetic macular edema: a systematic review and network meta-analysis. PLoS One. 2014;9(7):e102309.

    Article  PubMed  PubMed Central  Google Scholar 

  • Ringholm L, Mathiesen ER, Kelstrup L, et al. Managing type 1 diabetes mellitus in pregnancy—from planning to breastfeeding. Nat Rev Endocrinol. 2012;8(11):659–67.

    Article  CAS  PubMed  Google Scholar 

  • Robinson R, Barathi VA, Chaurasia SS, et al. Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals. Dis Model Mech. 2012;5(4):444–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rodrigues M, Xin X, Jee K, et al. VEGF secreted by hypoxic Muller cells induces MMP-2 expression and activity in endothelial cells to promote retinal neovascularization in proliferative diabetic retinopathy. Diabetes. 2013;62(11):3863–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Roider J, Brinkmann R, Wirbelauer C, et al. Subthreshold (retinal pigment epithelium) photocoagulation in macular diseases: a pilot study. Br J Ophthalmol. 2000;84(1):40–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Roider J, Liew SH, Klatt C, et al. Selective retina therapy (SRT) for clinically significant diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2010;248(9):1263–72.

    Article  PubMed  Google Scholar 

  • Romano MR, Gibran SK, Marticorena J, et al. Can a preoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous haemorrhage? Eye (Lond). 2009;23(8):1698–701.

    Article  CAS  Google Scholar 

  • Romero-Aroca P, Sagarra-Alamo R, Basora-Gallisa J, et al. Prospective comparison of two methods of screening for diabetic retinopathy by nonmydriatic fundus camera. Clin Ophthalmol. 2010;4:1481–8.

    Article  PubMed  PubMed Central  Google Scholar 

  • Rosberger DF. Diabetic retinopathy: current concepts and emerging therapy. Endocrinol Metab Clin North Am. 2013;42(4):721–45.

    Article  PubMed  Google Scholar 

  • Roy MS, Klein R. Macular edema and retinal hard exudates in African Americans with type 1 diabetes: the New Jersey 725. Arch Ophthalmol. 2001;119(2):251–9.

    CAS  PubMed  Google Scholar 

  • Russo A, Morescalchi F, Costagliola C, et al. Comparison of smartphone ophthalmoscopy with slit-lamp biomicroscopy for grading diabetic retinopathy. Am J Ophthalmol. 2015;159(2):360–4.

    Article  PubMed  Google Scholar 

  • Sacu S, Pemp B, Weigert G, et al. Response of retinal vessels and retrobulbar hemodynamics to intravitreal anti-VEGF treatment in eyes with branch retinal vein occlusion. Invest Ophthalmol Vis Sci. 2011;52(6):3046–50.

    Article  CAS  PubMed  Google Scholar 

  • Sander B, Larsen M, Engler C, et al. Early changes in diabetic retinopathy: capillary loss and blood-retina barrier permeability in relation to metabolic control. Acta Ophthalmol (Copenh). 1994;72(5):553–9.

    Article  CAS  Google Scholar 

  • Sander B, Best J, Johansen S, et al. Fluorescein transport through the blood-aqueous and blood-retinal barriers in diabetic macular edema. Curr Eye Res. 2003;27(4):247–52.

    Article  PubMed  Google Scholar 

  • Santos JM, Mohammad G, Zhong Q, et al. Diabetic retinopathy, superoxide damage and antioxidants. Curr Pharm Biotechnol. 2011;12(3):352–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Scanlon PH, Aldington SJ, Stratton IM. Epidemiological issues in diabetic retinopathy. Middle East Afr J Ophthalmol. 2013;20(4):293–300.

    Article  PubMed  PubMed Central  Google Scholar 

  • Scaramuzzi M, Querques G, Spina C, et al. Repeated intravitreal dexamethasone implant for diabetic macular edema. Retina. 2015;35:1216–22.

    Article  CAS  PubMed  Google Scholar 

  • Schiffman RM, Jacobsen G, Nussbaum JJ, et al. Comparison of a digital retinal imaging system and seven-field stereo color fundus photography to detect diabetic retinopathy in the primary care environment. Ophthalmic Surg Lasers Imaging. 2005;36(1):46–56.

    PubMed  Google Scholar 

  • Schmidt-Erfurth U, Lang GE, Holz FG, et al. Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study. Ophthalmology. 2014;121(5):1045–53.

    Article  PubMed  Google Scholar 

  • Schultz KL, Birnbaum AD, Goldstein DA. Ocular disease in pregnancy. Curr Opin Ophthalmol. 2005;16(5):308–14.

    Article  PubMed  Google Scholar 

  • Schwartz SG, Brantley Jr MA, Flynn Jr HW. Genetics and diabetic retinopathy. Curr Diabetes Rev. 2013;9(1):86–92.

    Article  PubMed  Google Scholar 

  • Schwartz SG, Flynn Jr HW, Scott IU. Emerging drugs for diabetic macular edema. Expert Opin Emerg Drugs. 2014;19(3):397–405.

    Article  CAS  PubMed  Google Scholar 

  • Sebag J. Abnormalities of human vitreous structure in diabetes. Graefes Arch Clin Exp Ophthalmol. 1993;231(5):257–60.

    Article  CAS  PubMed  Google Scholar 

  • Shah SM, Nguyen QD, Mir HS, et al. A randomized, double-masked controlled clinical trial of Sandostatin long-acting release depot in patients with postsurgical cystoid macular edema. Retina. 2010;30(1):160–6.

    Article  PubMed  Google Scholar 

  • Sheetz MJ, Aiello LP, Davis MD, et al. The effect of the oral PKC beta inhibitor ruboxistaurin on vision loss in two phase 3 studies. Invest Ophthalmol Vis Sci. 2013;54(3):1750–7.

    Article  CAS  PubMed  Google Scholar 

  • Shin HJ, Shin KC, Chung H, et al. Change of retinal nerve fiber layer thickness in various retinal diseases treated with multiple intravitreal antivascular endothelial growth factor. Invest Ophthalmol Vis Sci. 2014;55(4):2403–11.

    Article  PubMed  Google Scholar 

  • Shorb SR. Anemia and diabetic retinopathy. Am J Ophthalmol. 1985;100(3):434–6.

    Article  CAS  PubMed  Google Scholar 

  • Silva KC, Pinto CC, Biswas SK, et al. Hypertension increases retinal inflammation in experimental diabetes: a possible mechanism for aggravation of diabetic retinopathy by hypertension. Curr Eye Res. 2007;32(6):533–41.

    Article  CAS  PubMed  Google Scholar 

  • Silva PS, Sun JK, Al-Latayfeh MM, Sanchez CR, Walia S, Tolson AM, Cavallerano JD, Aiello LP. Unawareness of vision threatening diabetic retinopathy and appropriate followup in a tertiary telemedicine eye care program. Invest Ophthalmol Vis Sci. 2010;51:5059 (Abstract).

    Google Scholar 

  • Silva PS, Cavallerano JD, Haddad NM, et al. Peripheral lesions identified on ultrawide field imaging predict increased risk of diabetic retinopathy progression over 4 years. Ophthalmology. 2015;122(5):949–56.

    Article  PubMed  Google Scholar 

  • Sim DA, Keane PA, Zarranz-Ventura J, et al. Predictive factors for the progression of diabetic macular ischemia. Am J Ophthalmol. 2013a;156(4):684–92.

    Article  PubMed  Google Scholar 

  • Sim DA, Keane PA, Zarranz-Ventura J, et al. The effects of macular ischemia on visual acuity in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2013b;54(3):2353–60.

    Article  PubMed  Google Scholar 

  • Sim DA, Keane PA, Fung S, et al. Quantitative analysis of diabetic macular ischemia using optical coherence tomography. Invest Ophthalmol Vis Sci. 2014;55(1):417–23.

    Article  PubMed  Google Scholar 

  • Simha A, Braganza A, Abraham L, et al. Anti-vascular endothelial growth factor for neovascular glaucoma. Cochrane Database Syst Rev. 2013;10:CD007920.

    PubMed  PubMed Central  Google Scholar 

  • Simo R, Roy S, Behar-Cohen F, et al. Fenofibrate: a new treatment for diabetic retinopathy. Molecular mechanisms and future perspectives. Curr Med Chem. 2013;20(26):3258–66.

    Article  CAS  PubMed  Google Scholar 

  • Simunovic MP, Hunyor AP, Ho IV. Vitrectomy for diabetic macular edema: a systematic review and meta-analysis. Can J Ophthalmol. 2014;49(2):188–95.

    Article  PubMed  Google Scholar 

  • Sivak-Callcott JA, O’Day DM, Gass JD, et al. Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology. 2001;108(10):1767–76.

    Article  CAS  PubMed  Google Scholar 

  • Snead DR, James S, Snead MP. Pathological changes in the vitreoretinal junction 1: epiretinal membrane formation. Eye (Lond). 2008;22(10):1310–7.

    Article  CAS  Google Scholar 

  • Snow V, Weiss KB, Mottur-Pilson C. The evidence base for tight blood pressure control in the management of type 2 diabetes mellitus. Ann Intern Med. 2003;138(7):587–92.

    Article  PubMed  Google Scholar 

  • Sohn EH, He S, Kim LA, et al. Angiofibrotic response to vascular endothelial growth factor inhibition in diabetic retinal detachment: report no. 1. Arch Ophthalmol. 2012;130(9):1127–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sonoda S, Sakamoto T, Shirasawa M, et al. Correlation between reflectivity of subretinal fluid in OCT images and concentration of intravitreal VEGF in eyes with diabetic macular edema. Invest Ophthalmol Vis Sci. 2013;54(8):5367–74.

    Article  CAS  PubMed  Google Scholar 

  • Sophie R, Lu N, Campochiaro PA. Predictors of functional and anatomic outcomes in patients with diabetic macular edema treated with Ranibizumab. Ophthalmology. 2015;122:1395–401.

    Article  PubMed  Google Scholar 

  • Stamler J, Vaccaro O, Neaton JD, et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care. 1993;16(2):434–44.

    Article  CAS  PubMed  Google Scholar 

  • Stefansson E. Ocular oxygenation and the treatment of diabetic retinopathy. Surv Ophthalmol. 2006;51(4):364–80.

    Article  PubMed  Google Scholar 

  • Stewart MW. Anti-VEGF therapy for diabetic macular edema. Curr Diab Rep. 2014;14(8):510.

    Article  PubMed  CAS  Google Scholar 

  • Stitt AW. AGEs and diabetic retinopathy. Invest Ophthalmol Vis Sci. 2010;51(10):4867–74.

    Article  PubMed  Google Scholar 

  • Su CC, Yang CH, Yeh PT, et al. Macular tractional retinoschisis in proliferative diabetic retinopathy: clinical characteristics and surgical outcome. Ophthalmologica. 2014;231(1):23–30.

    Article  PubMed  Google Scholar 

  • Tahrani AA, Bailey CJ, Del PS, et al. Management of type 2 diabetes: new and future developments in treatment. Lancet. 2011;378(9786):182–97.

    Article  CAS  PubMed  Google Scholar 

  • Tamborlane WV, Beck RW, Bode BW, et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359(14):1464–76.

    Article  PubMed  Google Scholar 

  • Tang J, Kern TS. Inflammation in diabetic retinopathy. Prog Retin Eye Res. 2011;30(5):343–58.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tarr JM, Kaul K, Chopra M, et al. Pathophysiology of diabetic retinopathy. ISRN Ophthalmol. 2013;2013:343560.

    Article  PubMed  PubMed Central  Google Scholar 

  • Taylor E, Dobree JH. Proliferative diabetic retinopathy. Site and size of initial lesions. Br J Ophthalmol. 1970;54(1):11–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000;342(6):381–9.

    Article  PubMed Central  Google Scholar 

  • The Royal College of Ophthalmologists. Diabetic Retinopathy Guidelines. London: Royal College of Ophthalmologists; 2012.

    Google Scholar 

  • Theodossiadis PG, Theodoropoulou S, Neamonitou G, et al. Hemodialysis-induced alterations in macular thickness measured by optical coherence tomography in diabetic patients with end-stage renal disease. Ophthalmologica. 2012;227(2):90–4.

    Article  PubMed  Google Scholar 

  • Thulliez M, Angoulvant D, Le Lez ML, et al. Cardiovascular events and bleeding risk associated with intravitreal antivascular endothelial growth factor monoclonal antibodies: systematic review and meta-analysis. JAMA Ophthalmol. 2014;132(11):1317–26.

    Article  PubMed  Google Scholar 

  • Tokuyama T, Ikeda T, Sato K. Effects of haemodialysis on diabetic macular leakage. Br J Ophthalmol. 2000;84(12):1397–400.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ugurlu N, Gerceker S, Yulek F, et al. The levels of the circulating cellular adhesion molecules ICAM-1, VCAM-1 and endothelin-1 and the flow-mediated vasodilatation values in patients with type 1 diabetes mellitus with early-stage diabetic retinopathy. Intern Med. 2013;52(19):2173–8.

    Article  PubMed  Google Scholar 

  • UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317(7160):703–13.

    Article  Google Scholar 

  • Varma R, Torres M, Pena F, et al. Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino eye study. Ophthalmology. 2004;111(7):1298–306.

    Article  PubMed  Google Scholar 

  • Venkatesh P, Ramanjulu R, Azad R, et al. Subthreshold micropulse diode laser and double frequency neodymium: YAG laser in treatment of diabetic macular edema: a prospective, randomized study using multifocal electroretinography. Photomed Laser Surg. 2011;29(11):727–33.

    Article  CAS  PubMed  Google Scholar 

  • Verma A, Raman R, Vaitheeswaran K, et al. Does neuronal damage precede vascular damage in subjects with type 2 diabetes mellitus and having no clinical diabetic retinopathy? Ophthalmic Res. 2012;47(4):202–7.

    Article  CAS  PubMed  Google Scholar 

  • Vestgaard M, Ringholm L, Laugesen CS, et al. Pregnancy-induced sight-threatening diabetic retinopathy in women with type 1 diabetes. Diabet Med. 2010;27(4):431–5.

    Article  CAS  PubMed  Google Scholar 

  • Vijan S, Hofer TP, Hayward RA. Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. JAMA. 2000;283(7):889–96.

    Article  CAS  PubMed  Google Scholar 

  • Virgili G, Parravano M, Menchini F, et al. Anti-vascular endothelial growth factor for diabetic macular oedema. Cochrane Database Syst Rev. 2014;10:CD007419.

    PubMed  Google Scholar 

  • Voykov B, Bartz-Schmidt KU. Dislocation of dexamethasone intravitreous implant. Arch Ophthalmol. 2012;130(6):706.

    Article  PubMed  Google Scholar 

  • Vujosevic S, Bini S, Midena G, et al. Hyperreflective intraretinal spots in diabetics without and with nonproliferative diabetic retinopathy: an in vivo study using spectral domain OCT. J Diabetes Res. 2013;2013:491835.

    PubMed  PubMed Central  Google Scholar 

  • Wang H, Chhablani J, Freeman WR, et al. Characterization of diabetic microaneurysms by simultaneous fluorescein angiography and spectral-domain optical coherence tomography. Am J Ophthalmol. 2012a;153(5):861–7.

    Article  PubMed  PubMed Central  Google Scholar 

  • Wang ZY, Zhao KK, Zhao DS, et al. Dissection under perfluorocarbon liquid: a modified vitrectomy technique for diabetic tractional retinal detachment. Retina. 2012b;32(4):848–52.

    Article  PubMed  Google Scholar 

  • Wang Y, Muqit MM, Stanga PE, et al. Spatial changes of central field loss in diabetic retinopathy after laser. Optom Vis Sci. 2014;91(1):111–20.

    Article  PubMed  Google Scholar 

  • Wells JA, Glassman AR, Ayala AR, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015;372(13):1193–203.

    Article  CAS  PubMed  Google Scholar 

  • West SK, Klein R, Rodriguez J, et al. Diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VER. Diabetes Care. 2001;24(7):1204–9.

    Article  CAS  PubMed  Google Scholar 

  • Wilson DJ, Finkelstein D, Quigley HA, et al. Macular grid photocoagulation. An experimental study on the primate retina. Arch Ophthalmol. 1988;106(1):100–5.

    Article  CAS  PubMed  Google Scholar 

  • Witkin SR, Klein R. Ophthalmologic care for persons with diabetes. JAMA. 1984;251(19):2534–7.

    Article  CAS  PubMed  Google Scholar 

  • Wong CW, Wong TY, Cheng CY, et al. Kidney and eye diseases: common risk factors, etiological mechanisms, and pathways. Kidney Int. 2014;85(6):1290–302.

    Article  PubMed  Google Scholar 

  • Yalvac IS, Eksioglu U, Satana B, et al. Long-term results of Ahmed glaucoma valve and Molteno implant in neovascular glaucoma. Eye (Lond). 2007;21(1):65–70.

    Article  CAS  Google Scholar 

  • Yamagishi S, Ueda S, Matsui T, et al. Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy. Curr Pharm Des. 2008;14(10):962–8.

    Article  CAS  PubMed  Google Scholar 

  • Yamamoto T, Takeuchi S, Sato Y, et al. Long-term follow-up results of pars plana vitrectomy for diabetic macular edema. Jpn J Ophthalmol. 2007;51(4):285–91.

    Article  PubMed  Google Scholar 

  • Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–64.

    Article  PubMed  PubMed Central  Google Scholar 

  • Yilmaz T, Weaver CD, Gallagher MJ, et al. Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review. Ophthalmology. 2009;116(5):902–11.

    Article  PubMed  Google Scholar 

  • Yuen J, Clark A, Ng JQ, et al. Further survey of Australian ophthalmologist’s diabetic retinopathy management: did practice adhere to National Health and Medical Research Council guidelines? Clin Exp Ophthalmol. 2010;38(6):613–9.

    Article  Google Scholar 

  • Zabetian A, Keli HM, Echouffo-Tcheugui JB, et al. Diabetes in the Middle East and North Africa. Diabetes Res Clin Pract. 2013;101(2):106–22.

    Article  PubMed  Google Scholar 

  • Zandbergen AA, Vogt L, de ZD, et al. Change in albuminuria is predictive of cardiovascular outcome in normotensive patients with type 2 diabetes and microalbuminuria. Diabetes Care. 2007;30(12):3119–21.

    Article  CAS  PubMed  Google Scholar 

  • Zechmeister-Koss I, Huic M. Vascular endothelial growth factor inhibitors (anti-VEGF) in the management of diabetic macular oedema: a systematic review. Br J Ophthalmol. 2012;96(2):167–78.

    Article  PubMed  Google Scholar 

  • Zenoni S, Comi N, Fontana P. Individualised treatment of proliferative diabetic retinopathy: optimal surgical timing improves long-term outcomes. EPMA J. 2010;1(1):78–81.

    Article  PubMed  PubMed Central  Google Scholar 

  • Zhang W, Liu H, Rojas M, et al. Anti-inflammatory therapy for diabetic retinopathy. Immunotherapy. 2011;3(5):609–28.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang L, Chen B, Tang L. Metabolic memory: mechanisms and implications for diabetic retinopathy. Diabetes Res Clin Pract. 2012;96(3):286–93.

    Article  CAS  PubMed  Google Scholar 

  • Zhang X, Zhao J, Zhao T, et al. Effects of intensive glycemic control in ocular complications in patients with type 2 diabetes: a meta-analysis of randomized clinical trials. Endocrine. 2015;49:78–89.

    Article  CAS  PubMed  Google Scholar 

  • Zheng Y, Kwong MT, Maccormick IJ, et al. A comprehensive texture segmentation framework for segmentation of capillary non-perfusion regions in fundus fluorescein angiograms. PLoS One. 2014;9(4):e93624.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Zhong Y, Li J, Chen Y, et al. Activation of endoplasmic reticulum stress by hyperglycemia is essential for Muller cell-derived inflammatory cytokine production in diabetes. Diabetes. 2012;61(2):492–504.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhu Y, Zhang T, Wang K, et al. Changes in choroidal thickness after panretinal photocoagulation in patients with type 2 diabetes. Retina. 2015;35(4):695–703.

    Article  PubMed  Google Scholar 

  • Zucchiatti I, Lattanzio R, Querques G, et al. Intravitreal dexamethasone implant in patients with persistent diabetic macular edema. Ophthalmologica. 2012;228(2):117–22.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Ophthalmology, Eberhard-Karl University Tübingen, Schleichstr. 12, Tübingen, 72076, Germany

    Focke Ziemssen

  2. Eye Center, Albert-Ludwigs-University Freiburg, Killianstr. 5, Freiburg im Breisgau, 79106, Germany

    Hansjürgen T. Agostini

Authors
  1. Focke Ziemssen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hansjürgen T. Agostini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Focke Ziemssen .

Editor information

Editors and Affiliations

  1. Eye Center at the Medical Center, University of Freiburg, Freiburg, Baden-Württemberg, Germany

    Andreas Stahl

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Ziemssen, F., Agostini, H.T. (2016). Diabetic Retinopathy. In: Stahl, A. (eds) Anti-Angiogenic Therapy in Ophthalmology. Essentials in Ophthalmology. Springer, Cham. https://doi.org/10.1007/978-3-319-24097-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-24097-8_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-24095-4

  • Online ISBN: 978-3-319-24097-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation